Has Lawrence Czer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $956 in general payments to Lawrence Czer, MD across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lawrence Czer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lawrence Czer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lawrence Czer, MD

Advanced Heart Failure and Transplant Cardiology · West Hollywood, CANPI 1972564201

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Abbott at 56.3% of the total. Reporting peaked in 2023 at $466 and has fallen 80.5% since, to $91 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in CA, where the typical reported total is $9,367.

$956in general payments, 2019–2025

Across 13 payments — averaging $73.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$539
Impulse Dynamics (USA) Inc.$277
E.r. Squibb & Sons, L.L.C.$121
Merck$20

$151,281in research payments, 2019–2025

Across 42 payments — averaging $3601.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Impulse Dynamics (USA) Inc.$136K
Abbott$16K

What the payments were for

Travel & lodging$192%
Food & beverage$93798%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	8	$539
Impulse Dynamics (USA) Inc.	3	$277
E.r. Squibb & Sons, L.L.C.	1	$121
Merck	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$956 in reported general payments places this provider in the 10th percentile of 111 advanced heart failure and transplant cardiology providers in California.

See all advanced heart failure and transplant cardiology providers in California →

Medicare billing

Part B allowed, 2024

$108,112

Medicare patients

184

Services billed

792

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EntrestoSacubitril/Valsartan	12	$10,004
Valganciclovir Hcl	13	$3,724
Nystatin	17	$1,429
Potassium Chloride	22	$1,138
Mycophenolate Mofetil	29	$1,093
Tacrolimus	11	$1,073
Nateglinide	16	$674
Warfarin Sodium	34	$627
Pantoprazole Sodium	57	$551
Bumetanide	15	$536
Metoprolol Succinate	14	$263
Gabapentin	17	$222
Prednisone	34	$198
Rosuvastatin Calcium	28	$174
Tamsulosin Hcl	19	$147

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in West Hollywood

Richard WrightSanta Monica$1.7M
James Heywoodla Jolla$1.2M
Hirsch MehtaSan Diego$494K
Teresa de MarcoSan Francisco$366K
Rajeev Mohanla Jolla$357K
Marcus UreySan Diego$341K
Munir JanmohamedSacramento$314K
Barry GreenbergSan Diego$270K
Ronald WittelesStanford$251K
Gurpreet SodhiSacramento$241K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →